However, when anti-Ro52 is detected in DM patients positive with anti-MDA5 antibody, anti-Ro52 exerts an effect on the clinical course often associated with lower survival rate, increased incidence and severity of ILD in DM [24]. This evidence concerns the gene IFIH1 and dermatomyositis.